19:10 , Aug 31, 2017 |  BC Innovations  |  Translation in Brief

Bringing home exosomes

Researchers at the University of California San Diego published the first proof-of-concept data showing Biological Dynamics Inc. 's exosome-on-a-chip platform can isolate the extracellular vesicles and their proteins in under 30 minutes, without damaging them....
08:00 , Nov 21, 2011 |  BC Week In Review  |  Clinical News

FGI-101-1A6: Phase Ia data

A double-blind, placebo-controlled Phase Ia trial in 48 healthy volunteers showed that single ascending-doses of FGI-101-1A6 were tolerated. Patients received placebo or 1 of 6 doses of IV FGI-101-1A6 ranging from 0.0017-10 mg/kg. The company...
07:00 , Oct 8, 2001 |  BC Week In Review  |  Company News

Myriad Genetics other research news

Researchers published in Cell that the Tsg101 protein, which functions in vacuolar protein sorting (Vps) and binds to an essential tetrapeptide (PTAP) motif of the HIV Gag protein and ubiquitin, is essential for HIV budding...
07:00 , Oct 8, 2001 |  BioCentury  |  Tools & Techniques

Myriad's budding technology

While the human immunodeficiency virus has been studied extensively, it appears that there are still new things to be learned. Myriad Genetics Inc. last week reported in Cell the discovery of a new cellular target...
08:00 , Jan 13, 1997 |  BC Week In Review  |  Company News

Stanford University other research news

Stanford researchers reported in Cell that they have discovered TSG101, a gene on chromosome 11 that is defective in almost half of the breast cancers the scientists studied. The gene was discovered using a technique...